Associations of Dietary Phosphorus Intake, Urinary Phosphate Excretion, and Fibroblast Growth Factor 23 With Vascular Stiffness in Chronic Kidney Disease

Journal of Renal Nutrition

Volumn 23, Issue 1, 2013, Pages 12-20

  Houston, Jessica ^a   Smith, Kelsey ^a   Isakova, Tamara ^a   Sowden, Nicole ^a   Wolf, Myles ^a   Gutiérrez, Orlando M ^b,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE;

AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; DIET; DISORDERS OF MINERAL, ELECTROLYTE AND METAL METABOLISM; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHOSPHATE INTAKE; RISK FACTOR; STATISTICAL MODEL; URINE;

AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIET; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PHOSPHATES; PHOSPHORUS METABOLISM DISORDERS; PHOSPHORUS, DIETARY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84871418073     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2011.12.009     Document Type: Article

References (40)

1. Block G.A., Klassen P.S., Lazarus J.M., Ofsthun N., Lowrie E.G., Chertow G.M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004, 15:2208-2218.
2. Young E.W., Albert J.M., Satayathum S., et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005, 67:1179-1187.
3. Eddington H., Hoefield R., Sinha S., et al. Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol 2010, 5:2251-2257.
4. Kestenbaum B., Sampson J.N., Rudser K.D., et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005, 16:520-528.
5. Dhingra R., Sullivan L.M., Fox C.S., et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007, 167:879-885.
6. Tonelli M., Sacks F., Pfeffer M., Gao Z., Curhan G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005, 112:2627-2633.
7. Jono S., McKee M.D., Murry C.E., et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000, 87:E10-E17.
8. Haut L.L., Alfrey A.C., Guggenheim S., Buddington B., Schrier N. Renal toxicity of phosphate in rats. Kidney Int 1980, 17:722-731.
9. Shuto E., Taketani Y., Tanaka R., et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 2009, 20:1504-1512.
10. Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 2007, 20:295-301.
11. Barsotti G., Giannoni A., Morelli E., et al. The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet. Clin Nephrol 1984, 21:54-59.
12. Gutierrez O.M., Januzzi J.L., Isakova T., et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009, 119:2545-2552.
13. Gutierrez O.M., Mannstadt M., Isakova T., et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008, 359:584-592.
14. Hsu H.J., Wu M.S. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 2009, 337:116-122.
15. Isakova T., Xie H., Yang W., et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011, 305:2432-2439.
16. Hansen T.W., Li Y., Staessen J.A., et al. Independent prognostic value of the ambulatory arterial stiffness index and aortic pulse wave velocity in a general population. J Hum Hypertens 2008, 22:214-216.
17. Kampus P., Kals J., Ristimae T., Fischer K., Zilmer M., Teesalu R. High-sensitivity C-reactive protein affects central haemodynamics and augmentation index in apparently healthy persons. J Hypertens 2004, 22:1133-1139.
18. Andrade J., Er L., Ignaszewski A., Levin A. Exploration of association of 1,25-OH2D3 with augmentation index, a composite measure of arterial stiffness. Clin J Am Soc Nephrol 2008, 3:1800-1806.
19. Ix J.H., De Boer I.H., Peralta C.A., et al. Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA. Clin J Am Soc Nephrol 2009, 4:609-615.
20. Kendrick J., Ix J.H., Targher G., Smits G., Chonchol M. Relation of serum phosphorus levels to ankle brachial pressure index (from the Third National Health and Nutrition Examination Survey). Am J Cardiol 2010, 106:564-568.
21. Nichols W.W., Singh B.M. Augmentation index as a measure of peripheral vascular disease state. Curr Opin Cardiol 2002, 17:543-551.
22. Covic A., Gusbeth-Tatomir P., Goldsmith D.J. Arterial stiffness in renal patients: an update. Am J Kidney Dis 2005, 45:965-977.
23. Wilkinson I.B., MacCallum H., Flint L., Cockcroft J.R., Newby D.E., Webb D.J. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000, 525(Pt 1):263-270.
24. Ikizler T.A., Greene J.H., Wingard R.L., Parker R.A., Hakim R.M. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 1995, 6:1386-1391.
25. Kramer H., Han C., Post W., et al. Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens 2004, 17:963-970.
26. Chaturvedi N., Bulpitt C.J., Leggetter S., et al. Ethnic differences in vascular stiffness and relations to hypertensive target organ damage. J Hypertens 2004, 22:1731-1737.
27. Antoniucci D.M., Yamashita T., Portale A.A. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006, 91:3144-3149.
28. Burnett S.M., Gunawardene S.C., Bringhurst F.R., Juppner H., Lee H., Finkelstein J.S. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 2006, 21:1187-1196.
29. Ferrari S.L., Bonjour J.P., Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 2005, 90:1519-1524.
30. Foley R.N., Collins A.J., Herzog C.A., Ishani A., Kalra P.A. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 2009, 20:397-404.
31. Mirza M.A., Larsson A., Lind L., Larsson T.E. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 2009, 205:385-390.
32. Gutierrez O.M., Isakova T., Smith K., Epstein M., Patel N., Wolf M. Racial differences in postprandial mineral ion handling in health and in chronic kidney disease. Nephrol Dial Transplant 2010, 25:3970-3977.
33. Isakova T., Gutierrez O.M., Smith K., et al. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant 2011, 26:584-591.
34. Oliveira R.B., Cancela A.L., Graciolli F.G., et al. Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?. Clin J Am Soc Nephrol 2010, 5:286-291.
35. Gonzalez-Parra E., Gonzalez-Casaus M.L., Galan A., et al. Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients. Nephrol Dial Transplant 2011, 26:2567-2571.
36. Moe S.M., Zidehsarai M.P., Chambers M.A., et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 2011, 6:257-264.
37. Isakova T., Wahl P., Vargas G.S., et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011, 79:1370-1378.
38. Oparil S., Izzo J.L. Pulsology rediscovered: commentary on the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113:1162-1163.
39. Nurnberger J., Keflioglu-Scheiber A., Opazo Saez A.M., Wenzel R.R., Philipp T., Schafers R.F. Augmentation index is associated with cardiovascular risk. J Hypertens 2002, 20:2407-2414.
40. Oenning L.L., Vogel J., Calvo M.S. Accuracy of methods estimating calcium and phosphorus intake in daily diets. J Am Diet Assoc 1988, 88:1076-1080.